By stalling generic competition, drugmakers cost Medicare and Medicaid nearly $12 billion in 2016, a Kaiser Health News analysis finds.
By Sydney Lupkin Kaiser Health News, St. Louis Post-Dispatch: Living
Wed, 05/23/2018 - 8:45am
By stalling generic competition, drugmakers cost Medicare and Medicaid nearly $12 billion in 2016, a Kaiser Health News analysis finds.